Honokiol Inhibits Osteoclast Differentiation and Function in Vitro-Reference-Cited by-同舟云学术

Honokiol Inhibits Osteoclast Differentiation and Function in Vitro

Published:2010 Issue:3 Volume:33 Page:487-492
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Hasegawa Shin-ichi¹,Yonezawa Takayuki²³,Ahn Jae-Yong¹,Cha Byung-Yoon²,Teruya Toshiaki²,Takami Masamichi⁴,Yagasaki Kazumi³⁵,Nagai Kazuo¹²,Woo Je-Tae¹²³

Affiliation:

1. Department of Biological Chemistry, Chubu University

2. Research Institute for Biological Functions, Chubu University

3. Department of Nutriproteomics, Graduate School of Medicine, The University of Tokyo

4. Department of Biochemistry, School of Dentistry, Showa University

5. Division of Agriscience and Bioscience, Institute of Symbiotic Science and Technology, Tokyo University of Agriculture and Technology

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

http://www.jstage.jst.go.jp/article/bpb/33/3/33_3_487/_pdf

Reference34 articles.

1. Osteoclast differentiation and activation

2. Modulation of osteoclast differentiation [published erratum appears in Endocr Rev 1992 May;13(2):191]

3. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

4. Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation

5. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traditional Chinese Medicines and Prescriptions Brought from China to Japan by a Monk (Jianzhen, Japanese: Ganjin): A Historical Review;Compounds;2022-10-18

2. Heterocyclic Anti-cancer Compounds Derived from Natural Sources with their Mechanism of Action;Key Heterocyclic Cores for Smart Anticancer Drug–Design Part I;2022-07-04

3. In vitro antimicrobial and antipro-inflammation potential of honokiol and magnolol against oral pathogens and macrophages;Journal of the Formosan Medical Association;2021-02

4. Synthesis and biological activities of drugs for the treatment of osteoporosis;European Journal of Medicinal Chemistry;2020-07

5. CaMKII(δ) regulates osteoclastogenesis through ERK, JNK, and p38 MAPKs and CREB signalling pathway;Molecular and Cellular Endocrinology;2020-05